Get started Log in

POLB — Poolbeg Pharma Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Price Monitoring Extension
09/01/2023 09:00
Positive Initial Data Analysis in POLB 001 Trial
09/01/2023 07:00
Brief: Poolbeg Pharma Identifies Potential Drug Candidates For Respiratory Syncytial Virus Infections
21/12/2022 07:28
Poolbeg identifies novel RSV drug candidates
21/12/2022 07:00
Metabolic diseases oral delivery licence signed
14/12/2022 07:00
Second Price Monitoring Extn
12/12/2022 14:05
Price Monitoring Extension
12/12/2022 14:00
POLB 001 LPS human challenge trial completed
12/12/2022 07:00
Influenza AI model build completed
29/11/2022 07:00
Price Monitoring Extension
18/11/2022 14:00
Second Price Monitoring Extn
17/11/2022 14:05
Price Monitoring Extension
17/11/2022 14:00
Capital Markets Day
17/11/2022 07:00
Poolbeg-led consortium awarded EUR 2.3m grant
15/11/2022 10:36
AI programme yields novel RSV drug targets
08/11/2022 07:00
Upcoming events participation
21/10/2022 07:00
Second Price Monitoring Extn
06/10/2022 16:40
Price Monitoring Extension
06/10/2022 16:35
Brief: Poolbeg Pharma Says CEO Bought 718,733 Ordinary Shares Of 0.02P Each In Co
06/10/2022 07:46
CEO Share Purchase
06/10/2022 07:00